Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1776PDF: 829HTML: 226 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1934PDF: 1193HTML: 336 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1363PDF: 987HTML: 496 -
OMENTAL SPLENOSIS MIMICKING PERITONEAL CARCINOMATOSIS
187PDF: 195HTML: 28 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1963PDF: 812HTML: 562 -
An unusual cause of anemia and encephalopathy
4082PDF: 883HTML: 1534 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2793PDF: 859HTML: 15023Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 334 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1592PDF: 933HTML: 2009Figure: 190Tables: 202ALL revision 1: 289response to reviewer: 196 -
How I treat acute and persistent sickle cell pain
2038PDF: 1146HTML: 649 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2074PDF: 114HTML: 30 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1342PDF: 759HTML: 531 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
759PDF: 478HTML: 6277 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1750PDF: 766HTML: 2349 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2466PDF: 1706HTML: 461 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1159PDF: 1113HTML: 492 -
-
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
9840PDF: 3310HTML: 1609 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1230PDF: 816HTML: 1786 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1260PDF: 733HTML: 1256 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3312PDF: 997HTML: 3166flowcytometric result of peripheral blood sample: 194 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2840PDF: 1165HTML: 3310 -
The diagnostic pitfalls of mucormycosis
999PDF: 741HTML: 287 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1586PDF: 911HTML: 1012figures: 204table 1: 204table2: 200table3: 204 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1731PDF: 841HTML: 963cover letter: 290







